The FTC sent warning letters to 25 health plan marketers over potentially deceptive marketing practices, following its earlier letters to healthcare services companies about price transparency. The post The FTC Is Flexing Its Muscle in Healthcare appeared first on MedCity News.
Flagship Pioneering unveiled Etcelera, a new startup formed by combining three of the firm’s portfolio companies. Etcelera’s approach to drug R&D focuses on “causal intelligence,” which Flagship defines as predicting and understanding cause and effect in biology. The post Flagship Merges 3 Startups to Turn Cause and Effect Insights Into Novel Medicines appeared first on…
Rebuilding trust across a fragmented healthcare landscape demands that payers and providers alike move beyond transactional relationships and prioritize transparency, empathy, and tailored communication. The post Healthcare’s Trust Crisis Is an Experience Crisis appeared first on MedCity News.
The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase. The post Looser Health IT Certification Requirements…
Health tech companies made several major funding announcements in October. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in October appeared first on MedCity News.
In this episode, we’re joined by Dr. Rani Aravamudhan, senior medical director of Artemis at Nomi Health. We discuss Nomi Health’s new research on endometriosis. The post MedCity FemFwd: The Gaps in Endometriosis Care appeared first on MedCity News.
Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage. The post Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor…
The federal government is testing whether artificial intelligence can help Medicare identify unnecessary medical care, speed up the prior authorization process, and reduce healthcare spending. But a new report based on evidence recovered from a lawsuit raises concerns about the AI experiment. The post 7 Potential Problems with Medicare’s AI Prior Authorization Experiment appeared first…
As health system dealmaking stays steady in 2026, Integris Health is joining Risant Health to accelerate value-based care. The partnership represents an integration of Risant Health’s capabilities into Integris’ existing system, rather than a traditional merger. The post Integris Health to Join Risant Health as Health System Dealmaking Stays Active appeared first on MedCity News.
Why should Medicare determine who is qualified to provide remote monitoring by asking who employs the nurse, rather than who is accountable for the patient’s care? The post CMS Is Regulating the Wrong Thing — Here’s How to Fix Remote Patient Monitoring Without Losing the Care appeared first on MedCity News.